Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2026-01-04 @ 2:30 PM
Study NCT ID:
NCT04891068
Status:
RECRUITING
Last Update Posted:
2025-06-10
First Post:
2021-05-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
Sponsor:
University of Illinois at Chicago
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2021-0215
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None